Ranch Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Ranch Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$330K	Buy	5,727 +1	+0%	+$57	0.1%	124
2026 Q1	$347K	Hold	5,726	–	–	0.13%	122
2025 Q4	$309K	Sell	5,726 -202	-3%	-$9.72K	0.11%	127
2025 Q3	$267K	Sell	5,928 -29,722	-83%	-$1.39M	0.1%	134
2025 Q2	$1.65M	Buy	35,650 +1,511	+4%	+$74.2K	0.72%	46
2025 Q1	$2.08M	Buy	34,139 +1,781	+6%	+$104K	0.99%	36
2024 Q4	$1.83M	Buy	32,358 +1,162	+4%	+$64.9K	0.86%	36
2024 Q3	$1.61M	Buy	31,196 +26,013	+502%	+$1.22M	0.76%	42
2024 Q2	$215K	Buy	5,183 +3	+0.1%	+$134	0.11%	139
2024 Q1	$281K	Buy	5,180 +3	+0.1%	+$153	0.15%	126
2023 Q4	$266K	Sell	5,177 -26	-0.5%	-$1.36K	0.17%	122
2023 Q3	$302K	Sell	5,203 -101	-2%	-$6.19K	0.21%	110
2023 Q2	$339K	Hold	5,304	–	–	0.24%	106
2023 Q1	$368K	Sell	5,304 -29	-0.5%	-$2.04K	0.27%	105
2022 Q4	$384K	Hold	5,333	–	–	0.3%	97
2022 Q3	$379K	Buy	5,333 +1	+0%	+$73	0.31%	97
2022 Q2	$411K	Buy	5,332 +2	+0%	+$152	0.32%	94
2022 Q1	$389K	Buy	5,330 +2	+0%	+$134	0.26%	105
2021 Q4	$332K	Buy	5,328 +1	+0%	+$59	0.22%	116
2021 Q3	$315K	Buy	+5,327	New	+$351K	0.2%	122
2021 Q2	–	Sell	-5,419	Closed	-$353K	–	119
2021 Q1	$342K	Sell	5,419 -83	-2%	-$5.16K	0.23%	111
2020 Q4	$341K	Sell	5,502 -1,118	-17%	-$68.7K	0.25%	104
2020 Q3	$399K	Sell	6,620 -11,278	-63%	-$679K	0.32%	89
2020 Q2	$1.11M	Buy	17,898 +1,511	+9%	+$90.4K	0.87%	21
2020 Q1	$913K	Buy	16,387 +11,609	+243%	+$710K	0.9%	21
2019 Q4	$307K	Sell	4,778 -33	-0.7%	-$1.89K	0.25%	112
2019 Q3	$244K	Buy	+4,811	New	+$226K	0.26%	116

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ranch Capital Advisors's BMY Position: Q2 2026 in Review

Ranch Capital Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.02% in Q2 2026, buying an estimated $57 and bringing the position to 5,727 shares worth $330K. The position accounts for 0.1% of the portfolio, ranked #124.

Ranch Capital Advisors first reported a position in BMY in Q3 2019 and has held it in 27 quarters since. The position peaked at $2.08M in Q1 2025. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Ranch Capital Advisors held 5,727 shares of Bristol-Myers Squibb worth $330K as of Q2 2026.
Ranch Capital Advisors bought 1 Bristol-Myers Squibb share in Q2 2026, an estimated $57.
Bristol-Myers Squibb made up 0.1% of Ranch Capital Advisors's portfolio in Q2 2026, its #124 holding.
Ranch Capital Advisors first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 27 quarters since.
Ranch Capital Advisors's Bristol-Myers Squibb position peaked at $2.08M in Q1 2025.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Ranch Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.